The present review aims to describe the epigenetic alterations observed in oral cancer linked to the exposure to alcohol and/or tobacco.
INTRODUCTION
Oral carcinoma is the most common neoplastic disease in the head and neck region and there are over 50 000 new cases in United States expected for 2018 (considering oral cavity and pharynx together) and over 10 000 estimated deaths because of this tumor type [1] . Oral cancer refers to tumors arising in the lips, hard palate, upper and lower alveolar ridges, anterior two-thirds of the tongue, sublingual region, buccal mucosa, retromolar trigone and floor of the mouth [2] . Oral squamous cell carcinoma (OSCC) is commonly preceded by oral premalignant lesions (OPML) such as oral leukoplakia, eritroplakia, and actinic cheilitis [3 & ]. OPML have a variable histopathological presence of epithelial dysplasia, and clinical and histological approaches are unable to predict lesion progression and malignant transformation. No screening tool suggested so far by the literature has succeeded to improve OPML diagnosis and prognosis, or helped to reduce oral cancer [4] . OPML clinical features can be heterogeneous and it is difficult to evaluate risk. Despite various classifications of dysplasia grading available, they fail to identify the one at high risk of malignant transformation [3 & ]. The biological understanding/characterization of oral carcinoma and its different stages of progression offer opportunities to identify key players that could be used as molecular markers.
In this review article, we focus on epigenetic changes described in oral carcinoma, related to two very important established risk factors: tobacco and alcohol.
Epigenetics refers to mechanisms that alter the phenotype without changing the DNA sequence. These phenomena comprise DNA methylation (methylation on the cytosine bases of the DNA, on CG dinucleotides, commonly referred to as CpG), noncoding RNAs [micro RNA (miRNA), long non-coding ribonucleic acid, and so on], histone posttranslation modifications (e.g., acetylation, methylation). These are important mechanisms for gene regulation in normal cells, they are key in the normal development process; they are physiologically dynamic and may present a tissue-specific pattern [5, 6] . Alteration in epigenetic machineries and/or patterns is observed in multiple conditions, including diseases such as cancer. As an example, changes in DNA methylation in regulatory regions (promoters) of genes may result in altered behavior in oncogenes and tumor suppression genes.
Therefore, the study of epigenetic alterations on cancer progression and dysplastic lesions helps to understand oral carcinogenesis. Promoter hypermethylation on genes with tumor suppressive characteristics are observed in healthy tissue adjacent to tumors and OPML, suggesting that these epigenetic modifications are early events in oral carcinogenesis [7, 8] . Hypermethylation of CpG islands in promoter regions is often associated with gene silencing and contributes to the typical hallmarks of a cancer cell that result from tumor suppressor gene inactivation [5] . The fact that epigenetic alterations are reversible offers an attractive opportunity of candidates for therapeutic targets (not discussed in the current review).
Epigenetic changes may occur in response to exposure to risk factors. It can be caused by external factors, including tobacco, alcohol, diet, pharmacological treatments. The relationship between tobacco consumption and genetic and epigenetic changes has been explored in several studies. Alexandrov et al. [9] observed a mutational signature for each cancer type depending on smoking status, the duration of the exposure (pack years), and pattern of exposure. Smoking is usually associated with altered methylated CpG loci, which is best reported in lung tissue of smokers [10] , or transversion cytosine to adenine (C>A) [11] .
Chronic alcohol consumption can also induce a sequence of epigenetic alterations. It causes the inhibition of the ubiquitin-proteasome pathway in the nucleus, which leads to changes in the turnover of transcriptional factors, histone-modifying enzymes, and, therefore, altered epigenetic mechanisms (this has been shown in humans and animal models) [12] [13] [14] .
The most recent common epigenetic alterations induced by tobacco and/or alcohol in the scenario of OSCC progression are summarized in Table 1 and Fig. 1 .
EPIGENETIC CARCINOGENIC CHANGES IN ORAL SQUAMOUS CELL CARCINOMA INDUCED BY TOBACCO
Tobacco consumption is the main risk factor for developing OSCC, at least one-third of oral cancers are attributed to tobacco usage [26] . The relative risk of oral cancer for smokers compared with nonsmokers is between two and three [27] . Tobacco, both in its chewable and smoking forms, contains more than 60 carcinogens; a quarter of those carcinogens are proven to be carcinogenic in humans, with polycyclic aromatic hydrocarbons and Nnitrosamines being the most critical ones [28] . Tobacco participates in early carcinogenic stages inducing allelic losses at 3p11, 5g11, 9p21, 17p13, 18q12, gains at 11q13, amplification of the cyclin D1 (CCND1) gene, loss of p16, p15, and tumor protein 53 (TP53) mutations.
The main carcinogenic mechanism by tobacco is the formation of covalent bonds between the different carcinogens and DNA, which lead to the development of tobacco-related DNA adducts, and consequently the accumulation of several mutations in critical genes such as oncogenes and tumor-suppressor genes [29] . Covalent DNA adducts are considered a major DNA damage, which has been shown to alter DNA methylation by various mechanisms associated with the formation of DNA lesions or by inhibition of DNA
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Smoking cessation reverts certain epigenetic marks acquired throughout the years of exposure and these data should reinforce the importance of cessation.
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methyltransferases. Cigarette smoke causes hypomethylation by inducing chronic methylation via the reactive oxygen species [30] . (The relationship between cigarette smoking and DNA methylation is revised in [31] ).
Dibenzo[def,p]chrysene (DBP) is the most potent carcinogenic polycyclic aromatic hydrocarbons found in tobacco that induces oral cancer in animal models [32] . Mice treated with DBP developed maximum DNA damage, which included 30 and 48 differentially methylated CpG sites [20 & ]. These methylated sites were mapped to genes known to be involved in cancer-related pathways. The most significant finding was intronic hypomethylation of fibroblast growth factor 3 (FGF3) (correlating with gain of expression), observed in an early stage of the OSCC development but not evident in control oral mucosa not treated with DBP, and also intronic hypermethylation of vesicle associated membrane protein 3 (VAMP3) that was inversely correlated with its expression. These results indicate that tobacco carcinogen DBP plays an essential role in oral carcinogenesis induced by tobacco and that it affects methylation with the gene body, changing expression patterns and these epigenetic changes may serve as a potential biomarkers for early detection of OSCC [20 & ]. An inverse correlation was found between cigarette smoking and global or genome-wide DNA methylation [33, 34] . These could be accounted for gene body methylation as well as gene-specific hypomethylation that has been associated with activation of oncogenes and loss of genomic integrity. Hypomethylation can also lead to inappropriate recombinations resulting in defects in cell cycle monitoring, checkpoint genes, and genes involved in chromosome condensation and stability [33] .
A recurrent finding of a connexion between promoter methylation and cigarette consumptions is on the cyclin dependent kinase inhibitor 2A (CDKN2a, alias p16, INK4a) gene. A significant correlation was found between promoter methylation of CDKN2a and tobacco carcinogens, with a significantly higher proportion of promoter methylation in patients who started smoking at a younger age [15] . CDKN2a regulates the retinoblastoma pathway, leading to inhibition of cell cycle progression in the cell cycle transition between phase G1 to S transition, and therefore, acts as a tumor suppressor that is implicated in the prevention of carcinogenesis. Its inactivation is widely prevalent in head and neck squamous cell carcinoma (HSNCC), and it plays a critical role in the carcinogenesis process [6] . Chewing tobacco was also found to cause concurrent aberrant methylation in the promoter regions of CDKN2a detected by methylation-specific PCR assay. This methylation pattern was observed in both cancerous cells and adjacent normal mucosa of smokers. The overall methylation in the primary tumors was 86.7%, compared with 76% in adjacent healthy tissues. On the other hand, no aberrant methylation was detected in buccal scrapings from healthy individuals with no tobacco habits [16] . E-cadherin is encoded by the cadherin 1 (CDH1) gene, and it is a transmembrane glycoprotein, with five extracellular and one cytoplasmic domain. This molecule plays a vital role in creating adhesive junctions, cell polarity, and intracellular signaling. It acts as a tumor suppressor gene, and its absence is related to cell invasion and metastasis [34] . E-cadherin was also found hypermethylated in OSCC cells related to tobacco consumption. The promoter methylation was further associated with increased pack-years smoked [15] . Methylation of CpG sites in E-Cadherin expands through time and the longest time of exposure will lead to a more considerable amount of de novo methylation, which explains the higher portion of promoter methylation in E-Cadherin in patients with higher pack-years of smoking.
P15 is an effector of transforming growth factor b-induced cell cycle arrest. Inactivation of P15 by promoter hypermethylation has been observed in many human malignancies, suggesting that its downregulation may be essential in neoplastic transformation. Aberrant methylated P15 gene was found in higher proportion in the oral mucosa of healthy smokers (68%), compared with nonsmokers mucosa (8%). It was also found methylated in 64% of OSCC patients, who were heavy smokers [18] . Liu et al. showed that patients with smoking history of more than 20 years presented a higher significant association with death associated protein kinase 1 (DAPK) hypermethylation [19] .
Smoking was also shown to affect methylation patterns throughout the repetive element retrotransposable element 1 (LINE-1) [21] . LINE-1 is usually assessed to measure global methylation, because it is found repeatedely along the genome [22] . The interesting observation by Wangsri et al. [21] was Tobacco and alcohol induced epigenetic oral changes Ghantous et al.
that certain locus gained, whereas other lost methylation in smokers when compared with never smokers. These alterations seem to be proportional to the amount of cigarette smoked and seem to persist even after 1 year of stopping smoking. When the patients also consumed alcohol, the pattern did not particularly change, although gain of overall methylation was observed. These observations together with the recently gained knowledge that individual CpGs sites (even outside of CpG islands) [9,20 & ,21] are altered by exposure highlight that the influences of these risk factors in the epigenetic patterns need to be assessed in details to understand their real effects.
Tobacco carcinogens play an essential role in the development of oral carcinoma in its early stages and causes different epigenetic alterations. Recognizing these alterations can potentially lead to earlier diagnosis and targeted treatment.
Tobacco cessation
Smoking-induced epigenetic changes have been recently found to be dynamic and partially reversible by genome-wide methylation profiling. A study conducted by Guida et al. showed that there are two distinct classes of CpG sites which were affected by smoking cessation [35] . Sites which methylation reverts to levels typical of never smokers within decades after smoking cessation, and sites remaining differentially methylated, even more than 35 years after smoking cessation [35, 36] .
These findings indicate the presence of historical tobacco signatures, which could be used as biomarkers to refine individual risk profiling of smoking-induced chronic disease such as OSCC.
These epigenetic data highlight the importance of smoking cessation education for the benefit of the patient and even further emphasize that the most important strategy is preventing the start of smoking, once some of these studied epigenetic marks are not reversible even after years of smoking cessation.
EPIGENETIC CARCINOGENIC CHANGES IN ORAL SQUAMOUS CELL CARCINOMA INDUCED BY ALCOHOL
Alcohol consumption is a known etiological factor for many diseases, and is responsible for a large number of deaths worldwide [37] . It has been classified as a carcinogenic factor by International Agency for Research on Cancer, and is associated with cancer of the oral cavity, pharynx, larynx, esophagus, liver, pancreas, colorectum, and others [37] . Patient attributable risk for head and neck cancer for patients smoking and drinking was reported as high as 74% (80% for men and 61% for women), confirming a multiplicative joint effect between tobacco and alcohol [38] . Alcohol consumption alone has a comparatively lower risk for head and neck cancer, usually associated with high doses and with worse impact on pharyngeal and laryngeal cancers [39] . Shingler et al. [40] reported that three alcoholic drinks per day (considered as a high dose) in nonsmoker patients could increase 2.04 the risk of head and neck cancer. In addition, patients who continue to drink after treatment have a higher risk of recurrence and second primary tumors [41] .
The mechanisms associated with alcohol carcinogenic effect might include DNA damage induced by ethanol and its metabolite, acetaldehyde. DNA methylation is affected by altering folate metabolism and transmethylation reactions [42] . It can also alter DNA methyltransferases activity; therefore, chronic low dose of alcohol intake is associated with global hypomethylation, and higher doses induce gene-specific DNA hypermethylation, both showing carcinogenic consequences.
Acetaldehyde is produced in the oral cavity, as well in the kidney and the liver, and has a mutagenic effect. Studies on long non-coding RNAs have indicated its association with cancer progression on different types of epithelial cancer, including HSNCC [43] . Yu et al. [24] reported the role of long non-coding RNAs on the pathogenesis of alcoholassociated HNSCC and demonstrated the dysregulation of lnc-PSD4-1 and lnc-NETO1-1 in oral keratinocytes exposed to alcohol and acetaldehyde. Alcohol has also been shown to influence another type of non-coding RNAs, micro RNAs. Saad et al. [23] used a cohort to identify epigenetic alterations associated with alcohol consumption in nonsmoker patients. Four micro RNA (miR-30a, miR-934, miR-3164, and miR-3178) were upregulated in oral keratinocytes exposed to ethanol and acetaldehyde, suggesting participation on early events of oral carcinogenesis. They showed that the expression of miR-30a and miR-934 promotes the induction of B-cell lymphoma 2 (gene related to apoptosis) (BCL-2), an antiapoptotic gene, as well as increased cellular proliferation. These findings point to more relevant roles of alcohol as an independent risk factor on HNSCC carcinogenesis.
Alcohol has already been associated with DNA methylation, histone acetylation, and histone methylation during carcinogenesis. Urvalek et al. [25] found global carcinogenic epigenetic alterations associated to 4-nitroquinoline-1-oxide, a carcinogen and ethanol exposure. They observed that the exposure to these substances increases lysine on histone H3 (H3K)9/14 and H3K27 acetylation, and methylation on H3K27 and H3K9. They report global increase in histone modifications during oral carcinogenesis, associated to poor prognosis, increased metastasis, and increased recurrence rates.
Smith et al. [22] demonstrated a global hypomethylation associated with smoking and/or alcohol, and they point the difficulty to separate tobacco and alcohol effect as they can be confounding in characteristic in HNSCC patients. Another study investigated methylation of five tumor suppressor genes' regulatory/promoter region [P16, DAPK, adenomatous polyposis coli (APC), CDH1 and O-6-methylguanine-DNA methyltransferase (MGMT)] in OSCC and found a higher proportion of multiple gene hypermethylation in male patients and a trend of association between concurrent methylation and alcohol consumption [17] . They did not show single gene association but demonstrated as within this group of genes, they could observe higher methylation proportional to the alcohol consumption data.
Alcohol cessation decreases HNSCC risk annually and the risk becomes similar to never drinkers after 20 years of quitting. More accurate data can be difficult to be analyzed because of tobacco frequent concomitant use [44 && ].
CONCLUSION AND VISION
The study of epigenetic alterations in oral cancer progression and dysplastic lesions helps to understand oral carcinogenesis. Oral cancer and oral cancer progression are intimately associated with tobacco and alcohol consumption and epigenetic aberrations induced by these factors are increasingly being described. Oral cancer is the most common head and neck cancer and was chosen as the specific focus of this review.
There are several data showing that epigenetic changes occur in early stages of oral carcinogenesis, and even in adjacent normal tissue. Coupled with the malleability of these changes, that supports the idea of the possibility of reversing those alterations.
Understanding the molecular consequences of known risk factors such as alcohol and tobacco are the foundation for choosing and implementing strategies to prevent the exposure to such risk factors, to identify and put in practice intervention actions, to create and implement effective risk assessment approaches, to support awareness campaigns. Building the molecular knowledge of the consequences on a specific tissue type will aid the translational scientific community to identify markers that could open doors for risk assessment, early diagnosis, follow-up, and development of therapy targets and prevention tactics. There is a lot of accumulated knowledge on the epigenetic consequences of tobacco and/or alcohol consumption in the scenario of oral carcinoma that could benefit of large validation studies on prospective cohorts with follow-up after intervention and exposure/behavioral changes to allow these findings to progress to translational opportunities and advance the field of personalized medicine.
